Overview

High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study

Status:
Completed

Trial end date:
2012-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the complete response (CR) rate after HD-MTX induction chemotherapy followed by alternative HD MTX-based and HD Cytarabine-based combination consolidation chemotherapy

Phase:

Phase 2

Details

Lead Sponsor:

Samsung Medical Center

Treatments:

Cytarabine
Methotrexate
Vincristine